Corinne Gomez

A first-in-human phase I study of SAR125844, a selective MET tyrosine kinase inhibitor, in patients with advanced solid tumours with MET amplification

Eric Angevin, Gianluca Spitaleri, Jordi Rodón et al. · European Journal of Cancer · 2017 · 39 citations · Full text

Medicine, Oncology, Pharmacology +15

First‐in‐human trial of the PI3Kβ‐selective inhibitor SAR260301 in patients with advanced solid tumors

Philippe L. Bédard, Michael A. Davies, Scott Kopetz et al. · Cancer · 2017 · 34 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15

Phase I dose-escalation study of the c-Met tyrosine kinase inhibitor SAR125844 in Asian patients with advanced solid tumors, including patients with <i>MET</i>-amplified gastric cancer

Kohei Shitara, Tae Min Kim, Tomoya Yokota et al. · Oncotarget · 2017 · 25 citations · Full text

Medicine, Oncology, Pharmacology +11

Mechanism of deactivation and reactivation of Ziegler-Natta catalysts for propene polymerization

Alain Guyot, Roger Spitz, Jean‐Philippe Dassaud et al. · Journal of Molecular Catalysis · 1993 · 22 citations

Natural Sciences, Chemical Engineering, Chemistry +14

A phase II trial of nab-paclitaxel (NP) in patients with advanced pancreatic cancer (PC) who have progressed on gemcitabine (G)-based therapy.

Peter J. Hosein, Guilherme Lopes, Corinne Gomez et al. · Journal of Clinical Oncology · 2010 · 11 citations

Medicine, Oncology, Pharmacology +10